SCHEMBL8762018

SCHEMBL8762018

Cc1c(C(F)(F)F)[nH]c(=O)n(-c2cccc(C=C(Cl)C(=O)O)c2)c1=O

nearest known ligand 0.36

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.36
LMNA P02545 2/20 0.36
MAPK1 P28482 1/20 0.35
CYP1A2 P05177 1/20 0.34
NOTUM Q6P988 3/20 0.33
THRB P10828 1/20 0.33
GAA P10253 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.32
ALDH1A1 P00352 2/20 0.32
HPGD P15428 2/20 0.32
CYP2C9 P11712 1/20 0.32
CYP2C19 P33261 1/20 0.32
HIF1A Q16665 1/20 0.32
MAPT P10636 4/20 0.32
RAB9A P51151 1/20 0.31
TSHR P16473 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8761114 0.75 NOTUM (0.34) NOTUMSMN1; SMN2ALDH1A1
SCHEMBL7524485 0.72 NOTUM (0.34) KDM4ELMNANOTUMGAAALDH1A1
SCHEMBL7526227 0.72 NOTUM (0.34) KDM4ELMNANOTUMGAAALDH1A1
SCHEMBL8761988 0.70 NOTUM (0.31) NOTUM
SCHEMBL9221707 0.65 ATM (0.52) KDM4ELMNACYP1A2GAAALDH1A1
SCHEMBL8762022 0.63
SCHEMBL8345599 0.63 ALDH1A1 (0.32) KDM4ELMNACYP1A2ALDH1A1HPGD
SCHEMBL8612005 0.62 TP53 (0.34) KDM4ELMNACYP1A2NOTUMSMN1; SMN2
SCHEMBL7888968 0.62 RXFP1 (0.40) ALDH1A1MAPTTSHR
SCHEMBL22495466 0.62 HTT (0.40) KDM4ELMNASMN1; SMN2RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0770067-A1 SUBSTITUTED CINNAMIC OXIME AND HYDROXAMIDE DERIVATIVES BASF AKTIENGESELLSCHAFT (DE) 1997-05-02 EP disclosed
WO-1996002518-A1 SUBSTITUTED CINNAMIC OXIME AND HYDROXAMIDE DERIVATIVES BASF AKTIENGESELLSCHAFT (DE) 1996-02-01 WO disclosed